Cymbalta News
Most Popular Cymbalta Story
Profits rise at Novartis, Merck, Lilly
Good financial results from three Pharma biggies should cheer up those market-watchers who moaned their way through much of last week. Sure, a couple of the profit leaps came at least in part from Read more...
Latest Headlines
- January 5, 2012
- November 5, 2010
- September 17, 2010
- August 26, 2010
- August 19, 2010
- April 29, 2010
- January 6, 2010
- October 19, 2009
- August 31, 2009
- January 14, 2009
- August 26, 2008
- August 25, 2008
- June 30, 2008
- June 13, 2008
- April 21, 2008
- December 6, 2007
- October 3, 2007
- August 21, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
